nivolumab,ipilimumab
ono Pharmaceuticals,bms
['nivo', 'clear,data', 'clear,study', ' ipi ', 'bcsm', 'clear,result', 'tnbc', 'impact,(-impacte),(-impacti),(-impactf)', 'bellini']
from the overflow area, results of the nivo and nivo + ipi arms in tnbc with tils from the bellini basket study. data on: immune activation mri response and aspect after therapy impact of immune baseline features ctdna clearance #bcsm #esmo22 
Med Onc, Clinical Trials Development Leader @JulesBordet #BreastCancer #PrecisionMedicine. Views are mine https://t.co/PeEXATwb02